SCHEMBL19956963

SCHEMBL19956963

Cc1ccc2c(OC3CCCCCCC3)ccnc2c1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RIPK1 Q13546 1/20 0.46
HTR1A P08908 2/20 0.42
ADRA1D P25100 2/20 0.42
ADRA1A P35348 2/20 0.42
ADRA1B P35368 2/20 0.42
LRRK2 Q5S007 3/20 0.42
IRAK4 Q9NWZ3 1/20 0.40
AR P10275 3/20 0.40
LOX P28300 1/20 0.40
LOXL2 Q9Y4K0 1/20 0.40
KDM4E B2RXH2 1/20 0.39
ALDH1A1 P00352 1/20 0.39
L3MBTL1 Q9Y468 1/20 0.39
PDGFRB P09619 2/20 0.38
PDGFRA P16234 2/20 0.38
KMT5B Q4FZB7 1/20 0.38
KMT5C Q86Y97 1/20 0.38
KCNH2 Q12809 1/20 0.38
ALK Q9UM73 1/20 0.38
RIPK3 Q9Y572 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL29862588 0.85 ALK (0.47) HTR1AADRA1DADRA1AADRA1BIRAK4
Hydrochloric Acid SCHEMBL23360666 0.85 ALK (0.47) HTR1AADRA1DADRA1AADRA1BIRAK4
SCHEMBL19576192 0.79 IDO1 (0.51) AR
SCHEMBL12629435 0.76 HTR1A (0.53) HTR1AADRA1DADRA1AADRA1BPDGFRB
SCHEMBL23360413 0.76 PDE4D (0.52)
SCHEMBL29862539 0.76 PDE4D (0.52)
Hydrochloric Acid SCHEMBL23360586 0.74 TGFBR1 (0.48) HTR1AADRA1DADRA1AADRA1BIRAK4
SCHEMBL26086368 0.74 GAK (0.47) HTR1AADRA1DADRA1AADRA1BKMT5B
SCHEMBL10025294 0.73 HTR1A (0.34) RIPK1HTR1AADRA1DADRA1AADRA1B
SCHEMBL13016435 0.72 SRC (0.38) IRAK4ARALDH1A1PREP

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3293177-A1 TYROSINE KINASE INHIBITOR AND PHARMACEUTICAL COMPOSITION COMPRISING SAME GUANGDONG ZHONGSHENG PHARMACEUTICAL CO., LTD (CN) 2018-03-14 EP disclosed